← back to search

Jing Zhu

Nanjing University of Chinese Medicine · CN
Area of research
Cancer Research · Ophthalmology
Research interest
Research focused on Photodynamic therapy and Autophagy, with related work in Type 1 diabetes, Demethylase, Cancer research. Notable publications include 'The biological function of m6A demethylase ALKBH5 and its role in human disease', 'The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers', and 'Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide...'.
h-index
citations
525
works
9
NIH funding
primary concept
email

Recent publications

Pivotal epitopes for islet antigen-specific CD8+ T cell detection improve classification of suspected type 1 diabetes with the HLA-A*0201 allele
Immunologic Research 2025cited by 1position: middledoi
The biological function of m6A demethylase ALKBH5 and its role in human disease
Cancer Cell International 2020cited by 180position: middledoi
Hematoporphyrin monomethyl ether-mediated photodynamic therapy inhibits the growth of keloid graft by promoting fibroblast apoptosis and reducing vessel formation
Photochemical & Photobiological Sciences 2020cited by 21position: middledoi
[MiR-4443 promotes migration and invasion of breast cancer cells by inhibiting PEBP1 expression].
PubMed 2020cited by 9position: middledoi
Photodynamic therapy combined with dermatosurgical approach for Perifolliculitis Capitis Abscedens et Suffodiens
Photodiagnosis and Photodynamic Therapy 2020cited by 7position: middledoi
Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study
Diabetes Care 2019cited by 96position: middledoi
The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers
Medicine 2018cited by 162position: lastdoi
BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated with Cisplatin- or Docetaxel-Based Chemotherapy/Chemoradiotherapy
PLoS ONE 2013cited by 33position: middledoi
Prevalence of blindness and causes of visual impairment among adults aged 50 years or above in southern Jiangsu Province of China
Pakistan Journal of Medical Sciences 2013cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenyan Zhu · Nanjing University of Chinese Medicine2 papers (2020–2020)Xiaodong Yao · Nantong University2 papers (2020–2020)Quan Gu · University of Dundee2 papers (2020–2020)Xiaomei Cui · Nantong University2 papers (2020–2020)Jinqiu Wang · Ningbo University2 papers (2020–2020)Pan Xu · Nantong University2 papers (2020–2020)Jinyan Wang · Ningbo University2 papers (2020–2020)Yun Shi · Hebei Medical University1 papers (2025–2025)Wei Sun · Guangzhou University of Chinese Medicine1 papers (2013–2013)Xuqin Zheng · Nanjing Medical University1 papers (2025–2025)Ziyi Ji · Jinan University1 papers (2018–2018)Fan Yang · Jiangsu University1 papers (2025–2025)Yajun Ma · Fudan University1 papers (2020–2020)Baorui Liu · Nanjing University of Chinese Medicine1 papers (2013–2013)Yangqing Liu · Shanghai University1 papers (2013–2013)Xinyu Xu · Jiangsu University1 papers (2025–2025)Yun Cai · Shanghai Jiao Tong University1 papers (2025–2025)Quan-An Zhang · Nanjing Medical University1 papers (2020–2020)Lingling Bian · Nantong University1 papers (2025–2025)Quanan Zhang · Nanjing University of Chinese Medicine1 papers (2020–2020)